Nu Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,630 | 251,787 | 264,159 | 203,770 | 186,883 |
| Marketable Securities | 1,211 | 1,210 | 1,211 | 9,781 | 11,111 |
| Receivables | 39,544 | 48,892 | 59,703 | 56,576 | 50,784 |
| Inventories | 178,643 | 178,533 | 180,377 | 188,776 | 190,242 |
| Other current assets | 0 | 0 | 0 | 0 | 26,936 |
| TOTAL | $547,698 | $548,143 | $571,553 | $524,857 | $538,599 |
| Non-Current Assets | |||||
| PPE Net | 377,168 | 375,280 | 374,207 | 380,067 | 379,595 |
| Intangibles | 126,239 | 127,823 | 129,562 | 131,179 | 157,903 |
| Other Non-Current Assets | 354,208 | 373,160 | 368,371 | 355,308 | 392,817 |
| TOTAL | $857,615 | $876,263 | $872,140 | $866,554 | $930,315 |
| Total Assets | $1,405,313 | $1,424,406 | $1,443,693 | $1,391,411 | $1,468,914 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,000 | 20,000 | 35,000 | 20,000 | 30,000 |
| Accounts payable and accrued liabilities | 26,183 | 28,523 | 28,734 | 33,590 | 34,880 |
| Accrued Expenses | 217,551 | 205,914 | 220,172 | 206,710 | 217,808 |
| Other current liabilities | N/A | N/A | N/A | N/A | 13,919 |
| TOTAL | $263,734 | $254,437 | $283,906 | $260,300 | $296,607 |
| Non-Current Liabilities | |||||
| Long Term Debt | 204,187 | 209,044 | 213,900 | 218,757 | 363,613 |
| Other Non-Current Liabilities | 132,152 | 161,130 | 158,133 | 158,385 | 157,239 |
| TOTAL | $336,339 | $370,174 | $372,033 | $377,142 | $520,852 |
| Total Liabilities | $600,073 | $624,611 | $655,939 | $637,442 | $817,459 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,127 | 48,750 | 49,498 | 49,413 | 49,723 |
| Common Shares | 91 | 91 | 91 | 91 | 91 |
| Retained earnings | 1,860,319 | 1,848,734 | 1,834,617 | 1,816,462 | 1,711,949 |
| Other shareholders' equity | -116,164 | -117,191 | -114,469 | -124,061 | -124,372 |
| TOTAL | $805,240 | $799,795 | $787,754 | $753,969 | $651,455 |
| Total Liabilities And Equity | $1,405,313 | $1,424,406 | $1,443,693 | $1,391,411 | $1,468,914 |